This eye drop formulation indicated the high potency of cur-micelle in reducing VEGF expression in retinal cells (D407) and protection of them against oxidative stress. It shows sustained release profile for 1 month that is suitable for treatment of chronic retina diseases such as wet and dry AMD. Here, VEGFA is linked to dry age related macular degeneration.